Eli Lilly Gets FDA OK for Onswik Once-Weekly Insulin Injection
By Colin KellaherEli Lilly has won U.S. Food and Drug Administration approval for Onswik, a once-weekly basal insulin injection treatment for adults with type 2 diabetes.Eli Lilly on Thursday said Onswik is designed to deliver steady basal insulin levels over seven days, eliminating the need for mo…